1. Home
  2. CRNX vs DAKT Comparison

CRNX vs DAKT Comparison

Compare CRNX & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • DAKT
  • Stock Information
  • Founded
  • CRNX 2008
  • DAKT 1968
  • Country
  • CRNX United States
  • DAKT United States
  • Employees
  • CRNX N/A
  • DAKT N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • DAKT Office Equipment/Supplies/Services
  • Sector
  • CRNX Health Care
  • DAKT Industrials
  • Exchange
  • CRNX Nasdaq
  • DAKT Nasdaq
  • Market Cap
  • CRNX 2.8B
  • DAKT 710.0M
  • IPO Year
  • CRNX 2018
  • DAKT 1994
  • Fundamental
  • Price
  • CRNX $28.48
  • DAKT $15.15
  • Analyst Decision
  • CRNX Strong Buy
  • DAKT Strong Buy
  • Analyst Count
  • CRNX 10
  • DAKT 1
  • Target Price
  • CRNX $75.00
  • DAKT $26.00
  • AVG Volume (30 Days)
  • CRNX 626.1K
  • DAKT 484.4K
  • Earning Date
  • CRNX 08-07-2025
  • DAKT 06-25-2025
  • Dividend Yield
  • CRNX N/A
  • DAKT N/A
  • EPS Growth
  • CRNX N/A
  • DAKT N/A
  • EPS
  • CRNX N/A
  • DAKT N/A
  • Revenue
  • CRNX $760,000.00
  • DAKT $756,477,000.00
  • Revenue This Year
  • CRNX $402.12
  • DAKT N/A
  • Revenue Next Year
  • CRNX $770.88
  • DAKT $4.86
  • P/E Ratio
  • CRNX N/A
  • DAKT N/A
  • Revenue Growth
  • CRNX N/A
  • DAKT N/A
  • 52 Week Low
  • CRNX $24.10
  • DAKT $10.24
  • 52 Week High
  • CRNX $62.53
  • DAKT $19.89
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 34.75
  • DAKT 56.70
  • Support Level
  • CRNX $29.83
  • DAKT $13.30
  • Resistance Level
  • CRNX $30.85
  • DAKT $16.04
  • Average True Range (ATR)
  • CRNX 1.03
  • DAKT 0.65
  • MACD
  • CRNX -0.28
  • DAKT 0.10
  • Stochastic Oscillator
  • CRNX 3.36
  • DAKT 67.52

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: